Long-term and clinical profile of heart failure with recovered ejection fraction in a non-tertiary hospital

被引:3
|
作者
Martinez-Mateo, Virgilio [1 ]
Fernandez-Anguita, Manuel [1 ]
Cejudo, Laura [1 ]
Martin-Barrios, Eugenia [1 ]
Paule, Antonio J. [1 ]
机构
[1] Hosp Mancha Ctr, Serv Cardiol, Alcdzar De San Juan, Ciudad Real, Spain
来源
MEDICINA CLINICA | 2019年 / 152卷 / 02期
关键词
Heart failure with preserved ejection fraction; Heart failure with recovered ejection fraction; OUTCOMES; BIOMARKERS;
D O I
10.1016/j.medcli.2018.05.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Heart failure (HF) with recovered ejection fraction (EF) is emerging as a different HF subtype. There is little information about his clinical profile in hospitals that are not a reference. Methods: We analysed characteristics and prognosis in patients with recovered HF followed prospectively in the HF Unit of a non-tertiary hospital. Results: A total of 431 patients with HF with reduced EF were followed (median 50 months, 79.3% males, mean age 70.3 +/- 12.2 years). Of the patients, 26.9% (N 116) recovered EF, mainly in the first year of followup (76.7%). Compared with patients that did not recovered EF in the follow-up, they were younger, rate of ischemic origin of cardiomyopathy was less frequent and presented less comorbidity. Mortality was lower in patients with recovered HF (survival median of 85.2 +/- 2.1 vs. 74.2 +/- 1.9 months [log-rank x(2) 11.5, P=0.001], hazard ratio 0.37, 95% confidence interval [CI]: 0.21-0.67, P=0.002). Aetiology of deaths was not mainly secondary to HF. Younger age of 68 years (odds ratio [OR] 0-98, 95% CI: 0.96-0,99; P=0.025), ischemic origin (OR 1.12, 95% CI: 1.01-1.21; P=0.003) and use of aldosterone antagonists (OR 1.89, 95% CI: 1.09-3.26; P=0.023) were the variables independently associated to normalisation of EF. Conclusion: HF with recovered EF is a frequent phenomenon. It has a more favourable clinical course, prognosis and basal characteristics than HF with persistent reduced EF. Further studies are needed to identify natural history and optimal medications for HF-recovered patients. (C) 2018 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:50 / 54
页数:5
相关论文
共 50 条
  • [31] Acute heart failure with intermediate ejection fraction: clinical profile and short-term outcome
    Farmakis, D. T.
    Parissis, J.
    Simitsis, P.
    Bistola, V.
    Katsanos, S.
    Ikonomidis, I.
    Follath, F.
    Mebazaa, A.
    Filippatos, G.
    Lekakis, J.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 329 - 330
  • [32] Long-term outcomes in heart failure with preserved ejection fraction: predictors of cardiovascular and non-cardiovascular mortality
    Shahim, A.
    Hourqueig, M.
    Lund, L. H.
    Savarese, G.
    Oger, E.
    Daubert, J-C
    Linde, C.
    Hage, C.
    Donal, E.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 24 - 25
  • [33] Non-severe multivalvular regurgitation patterns and long-term mortality in heart failure with preserved ejection fraction
    De Oliveira, E. K.
    Shumkova, M.
    De Colle, C.
    Paolisso, P.
    Moya, A.
    Beles, M.
    Hrubyak, L.
    Kockova, R.
    Van Camp, G.
    Bartunek, J.
    Penicka, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 116 - 116
  • [34] Predictors of long-term prognosis of ambulatory patients with heart failure and preserved ejection fraction
    Sole Gonzalez, E. Eduard
    Alvarez-Garcia, J.
    Ferrero-Gregori, A.
    Carreras Mora, J.
    Mirabet Perez, S.
    Mendez Fernandez, A.
    Mesado Batalla, N.
    Pirla Buxo, M. J.
    Roig Minguell, E.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 270 - 271
  • [35] Long-term outcomes of acute heart failure with preserved left ventricular ejection fraction
    Seung-Jae, J.
    Joon-Hyouk, C.
    Song-Yi, K.
    Ki-Seok, K.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 11 - 11
  • [36] Long-term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non-cardiac mortality
    Shahim, Angiza
    Hourqueig, Marion
    Lund, Lars H.
    Savarese, Gianluigi
    Oger, Emmanuel
    Venkateshvaran, Ashwin
    Benson, Lina
    Daubert, Jean-Claude
    Linde, Cecilia
    Donal, Erwan
    Hage, Camilla
    [J]. ESC HEART FAILURE, 2023, 10 (03): : 1835 - 1846
  • [37] Predictors of long-term prognosis of ambulatory patients with heart failure and preserved ejection fraction
    Sole Gonzalez, E.
    Alvarez-Garcia, J.
    Ferrero-Gregori, A.
    Mirabet Perez, S.
    Mendez Fernandez, A.
    Brossa Loidi, V.
    Carreras Mora, J.
    Mesado Batalla, N.
    Pirla Buxo, M. J.
    Roig Minguell, E.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 127 - 128
  • [38] Sex differences in long-term health status in heart failure with preserved ejection fraction
    Flint, K. Kelsey
    Merrill, M.
    Kao, D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 327 - 327
  • [39] Predictors and Long-Term Clinical Impact of Heart Failure With Improved Ejection Fraction After Acute Myocardial Infarction
    Kim, Kyung An
    Kim, Sang Hyun
    Lee, Kwan Yong
    Yoon, Andrew H.
    Hwang, Byung-Hee
    Choo, Eun Ho
    Kim, Jin Jin
    Choi, Ik Jun
    Kim, Chan Joon
    Lim, Sungmin
    Park, Mahn-Won
    Yoo, Ki-Dong
    Jeon, Doo Soo
    Ahn, Youngkeun
    Jeong, Myung Ho
    Chang, Kiyuk
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (16):
  • [40] LONG-TERM CLINICAL OUTCOMES IN PEOPLE WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) TREATED WITH STANDARD CARE
    Sun, L.
    Dayer, V
    Hansen, R. N.
    Du, Y.
    Williamson, T.
    Kong, S. X.
    Mernagh, P.
    Singh, R.
    Folkerts, K.
    Allen, S.
    Sullivan, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S21 - S22